| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut National de la Santé et de la Recherche Médicale, E0018, Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire (C.J., O.B., D.P.-M., F.S., P.R., V.R., Y.M., P.R.), F-49033 Angers, France; Laboratoire dAnatomie Pathologique, Hôpital Ambroise Paré (B.F.), F-92104 Boulogne, France; and Laboratoire dAnatomie Pathologique, Centre Hospitalier Régional Universitaire (S.G.), F-37044 Tours, France
Address all correspondence and requests for reprints to: Dr. Caroline Jacques, Institut National de la Santé et de la Recherche Médicale, E0018, Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire dAngers, 4 rue Larrey, F-49033 Angers, France. E-mail: address: caroline.jacques{at}med.univ-angers.fr.
Thyroid oncocytic adenomas are a class of tumors characterized by the presence of abundant mitochondria. We performed a differential display RT-PCR analysis on two oncocytic adenomas and their paired controls. We then carried out a microarray analysis using the 460 selected, differentially expressed clones on four other oncocytomas and their paired controls. Thirty genes, 12 encoded by mitochondrial DNA and 18 nuclear-encoded, were overexpressed by a factor of at least 2 in the tumors compared with the controls. Seven of the 18 nuclear-encoded genes are involved in protein metabolism: DKFZP434I116, B3GTL, SNX19, RP42, SENP1, UBE2D3, and the CTSB gene, which is known to be particularly deregulated in most thyroid tumors. Other genes are implicated in signal transduction (ITGAV) or tumorigenesis (AF1q). Immunohistochemistry allowed us to confirm overexpression of the ITGAV and CTSB genes at the protein level and showed a marked relocation of the CTSB protein. We confirmed the overexpression of the AF1q oncogene in 56% of 18 oncocytic tumors by quantitative RT-PCR analysis, which attested to the heterogeneity of these tumors. Our results show an increased expression of genes involved in protein metabolism in oncocytoma, the significance of which requires investigation.
This article has been cited by other articles:
![]() |
K. Krause, M. Eszlinger, O. Gimm, S. Karger, C. Engelhardt, H. Dralle, and D. Fuhrer TFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1390 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bawa-Khalfe, J. Cheng, Z. Wang, and E. T. H. Yeh Induction of the SUMO-specific Protease 1 Transcription by the Androgen Receptor in Prostate Cancer Cells J. Biol. Chem., December 28, 2007; 282(52): 37341 - 37349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujarewicz, M. Jarzab, M. Eszlinger, K. Krohn, R. Paschke, M. Oczko-Wojciechowska, M. Wiench, A. Kukulska, B. Jarzab, and A. Swierniak A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping Endocr. Relat. Cancer, September 1, 2007; 14(3): 809 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors Endocr. Rev., May 1, 2007; 28(3): 322 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kozma, J. J. Keusch, B. Hegemann, K. B. Luther, D. Klein, D. Hess, R. S. Haltiwanger, and J. Hofsteenge Identification and Characterization of abeta1,3-Glucosyltransferase That Synthesizes the Glc-beta1,3-Fuc Disaccharide on Thrombospondin Type 1 Repeats J. Biol. Chem., December 1, 2006; 281(48): 36742 - 36751. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |